At the upcoming Vitafoods show in Geneva, Switzerland, May 14-16, Aker BioMarine (booth #15059) will be on hand to discuss the most recent developments with the company and its ingredient brand, Superba™ Krill.
On the clinical research front, Aker BioMarine has new findings to share about its most recent cardiovascular study. This trial evaluated Superba™ Krill’s ability to lower triglycerides without raising LDL cholesterol in those who have borderline high or high triglyceride levels.
Three hundred subjects participated in this randomized, double-blind, placebo-controlled, multi-center study. The five treatment groups included a placebo group (olive oil), as well as 4 groups taking .5, 1, 2 and 4 grams of Superba™ daily. The study showed a triglyceride-lowering effect-without impacting LDL levels. Study authors concluded from their findings that krill oil is effective in reducing cardiovascular risk factors important in the treatment of dyslipidemia.
The company has also released new survey findings out of Europe’s leading supplement markets pointing to the need for omega-3 alternatives such as Superba™ krill, especially in the UK, France and Germany.
According to the survey conducted by Discovery Research Group, a large percentage of consumers who identify themselves as omega-3 supplement users are looking for an alternative to existing sources. This was the case for 55% of consumers in France, 66% of consumers in Germany, and 47% of consumers in the UK.
Large capsule size, reflux, bad aftertaste and expense were cited as the top reasons respondents gave in the three markets for discontinuing use or not taking an omega-3 supplement at all. These findings are similar to a survey conducted in the US last year, where 37% of supplement consumers indicated they wanted an omega-3 other than fish oil.
When it comes to omega-3 supplement usage, fish oil is the most widely used in all three markets, while usage of krill oil is low, but growing. In the US, krill supplements have grown dramatically in the Food, Drug and Mass market channel, now accounting for 12% of all omega-3 supplement sales.
“Krill supplement sales have exploded in the US over the last three years and we wanted to pinpoint why this market grew so dramatically. So we commissioned a survey to better understand consumer behavior,” said Matts Johansen, COO, Aker BioMarine. “It seems to be the much improved user experience of smaller, easier-to-swallow capsules and digestive comfort that resonate most with consumers in the US. Now we see similar sentiments in Europe. There is a large percentage of consumers not being served by current omega-3 offerings, and Superba™ Krill can nicely fill this void.”
Superba™ krill from Aker BioMarine offers a superior user experience in the form of smaller pills and no digestive upset. Further, the omega-3s in krill are bound to phospholipids, making them more bio-efficient – getting into cells up to 60% better than other omega-3s.
Antarctic krill is sourced in the Southern Ocean, the purest waters on Earth. Because of their position on the food chain, krill don’t accumulate heavy metals or contaminants to the degree that other marine species do. Lastly, krill is naturally rich in astaxanthin, which keeps the omega-3s found in Superba™ Krill naturally fresh and stable.
At the upcoming Vitafoods show in Geneva, Switzerland on May 14-16 experts will be available at the Aker BioMarine booth (#15059) to discuss the company’s recent consumer studies in Europe, its clinical research activities, and its sustainability initiatives.
For further information, please contact: Roar Hernes, +47 (241) 30123 firstname.lastname@example.org
About SuperbaTM KrillOil
SuperbaTM Krill Oil is a pure, natural source of the health-promoting EPA & DHA omega-3 essential fatty acids and the naturally occurring antioxidant astaxanthin. The uniqueness of SuperbaTM Krill Oil is that the omega-3 fatty acids are provided in phospholipid form. In vitro, in vivo and human clinical research has demonstrated the safety and efficacy of SuperbaTM Krill Oil.
About Aker BioMarine
Aker BioMarine is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain from raw materials to customers. Aker BioMarine’s SuperbaTM Krill products are provided with 100-percent traceability from the Antarctic sea to the end user. Only Aker’s krill fishery has been awarded Marine Stewardship Council (MSC) Certification.